MannKind Corp
MannKind Corporation, a biopharmaceutical company, focuses on the provision of various solutions for transforming chronic disease care. It develops and commercializes treatments that address serious unmet medical needs, including diabetes, pulmonary hypertension, and fluid overload in heart failure and chronic kidney disease. It offers Afrezza inhalation powder, an inhaled insulin used to improve… Read more
MannKind Corp (MNKD) - Total Assets
Latest total assets as of September 2025: $494.64 Million USD
Based on the latest financial reports, MannKind Corp (MNKD) holds total assets worth $494.64 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
MannKind Corp - Total Assets Trend (2000–2024)
This chart illustrates how MannKind Corp’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
MannKind Corp - Asset Composition Analysis
Current Asset Composition (December 2024)
MannKind Corp's total assets of $494.64 Million consist of 68.1% current assets and 31.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 11.8% |
| Accounts Receivable | $11.80 Million | 3.0% |
| Inventory | $27.89 Million | 7.1% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $5.26 Million | 1.3% |
| Goodwill | $1.93 Million | 0.5% |
Asset Composition Trend (2000–2024)
This chart illustrates how MannKind Corp's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: MannKind Corp's current assets represent 68.1% of total assets in 2024, an increase from 0.0% in 2000.
- Cash Position: Cash and equivalents constituted 11.8% of total assets in 2024, up from 0.0% in 2000.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2000.
- Asset Diversification: The largest asset category is inventory at 7.1% of total assets.
MannKind Corp Competitors by Total Assets
Key competitors of MannKind Corp based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
MannKind Corp - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - MannKind Corp generates 0.72x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, MannKind Corp generates $7.00 in net profit.
MannKind Corp - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.29 | 4.54 | 1.08 |
| Quick Ratio | 3.04 | 4.17 | 1.01 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $249.71 Million | $ 255.56 Million | $ 5.77 Million |
MannKind Corp - Advanced Valuation Insights
This section examines the relationship between MannKind Corp's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 2.00 |
| Asset Growth Rate (YoY) | -17.1% |
| Total Assets | $393.84 Million |
| Market Capitalization | $786.22 Million USD |
Valuation Analysis
Above Book Valuation: The market values MannKind Corp's assets above their book value (2.00 x), reflecting positive investor sentiment about the company's future prospects.
Significant Asset Reduction: MannKind Corp's assets decreased by 17.1% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for MannKind Corp (2000–2024)
The table below shows the annual total assets of MannKind Corp from 2000 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $393.84 Million | -17.12% |
| 2023-12-31 | $475.20 Million | +60.93% |
| 2022-12-31 | $295.28 Million | -8.06% |
| 2021-12-31 | $321.16 Million | +195.71% |
| 2020-12-31 | $108.61 Million | +15.88% |
| 2019-12-31 | $93.72 Million | -12.98% |
| 2018-12-31 | $107.70 Million | +27.35% |
| 2017-12-31 | $84.58 Million | -21.00% |
| 2016-12-31 | $107.06 Million | -15.31% |
| 2015-12-31 | $126.41 Million | -67.95% |
| 2014-12-31 | $394.44 Million | +52.50% |
| 2013-12-31 | $258.65 Million | +2.92% |
| 2012-12-31 | $251.31 Million | +25.94% |
| 2011-12-31 | $199.55 Million | -28.03% |
| 2010-12-31 | $277.26 Million | +12.07% |
| 2009-12-31 | $247.40 Million | -12.41% |
| 2008-12-31 | $282.46 Million | -48.02% |
| 2007-12-31 | $543.44 Million | +0.69% |
| 2006-12-31 | $539.74 Million | +136.34% |
| 2005-12-31 | $228.37 Million | +39.69% |
| 2004-12-31 | $163.48 Million | +29.88% |
| 2003-12-31 | $125.88 Million | +20.14% |
| 2002-12-31 | $104.77 Million | +145.69% |
| 2000-12-31 | $42.65 Million | -- |